GlassScriptPhysician profile
Grace Catherine Darnell
NPI 1689164477
$2,003.70
in general payments reported to CMS, 2019-2025
23 companies · $531 in 2025
The $531 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $229 · 2023: $312 · 2024: $807 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,649.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $510.95 | 2021-2025 | Jemperli, Zejula, Ojjaara |
| E.R. Squibb & Sons, L.L.C. | $445.56 | 2024-2025 | Opdivo |
| Astrazeneca Pharmaceuticals LP | $202.45 | 2024-2025 | Lynparza |
| Tempus Ai, INC | $158.40 | 2025 | Xt Cdx |
| Takeda Pharmaceuticals U.S.A., INC. | $149.20 | 2022-2024 | Fruzaqla |
| Intuitive Surgical, INC. | $140.68 | 2023 | Da Vinci Surgical System |
| Genmab U.S., INC. | $41.40 | 2025 | Tivdak |
| Merck Sharp & Dohme LLC | $32.17 | 2025 | Keytruda |
| Astellas Pharma US INC | $31.39 | 2024 | Padcev |
| Boston Scientific Corporation | $29.82 | 2023 | Spaceoar Vue System - 10ml |
| Regeneron Healthcare Solutions, INC. | $29.12 | 2023 | Libtayo |
| Pharmacosmos Therapeutics INC. | $27.74 | 2024 | Monoferric |
| Aadi Bioscience, INC. | $21.77 | 2024 | Fyarro |
| Pharmaessentia USA Corporation | $21.58 | 2025 | Besremi |
| Kyowa Kirin, INC. | $19.93 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $19.65 | 2023 | |
| Progenics Pharmaceuticals, INC. | $19.48 | 2024 | |
| Incyte Corporation | $19.14 | 2023 | Monjuvi |
| Abbvie INC. | $17.93 | 2024 | |
| Jazz Pharmaceuticals INC. | $17.85 | 2025 | |
| Philips North America LLC | $16.60 | 2024 | (Ak6) Vest Therapy |
| Bioprotect Medical, INC. | $15.72 | 2025 | Bioprotect Balloon Implant System |
| Tactile Systems Technology INC | $15.17 | 2024 | Flexitouch Plus, Entre Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Darnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.